/Investor DB

SV Latam Fund — 2026 Investments

1 investments dated 2026 · listed companies and verified rows first · show all

Biomakersbiomakers.netinSeries A · Jan 2026 · $8M

Biomakers operates a precision oncology platform that combines genomic testing, clinical data, biobanking, and AI to support cancer care and drug and diagnostic development.

AI & Machine LearningBiotechData & InfrastructureDigital HealthHealthtechCity Of Dover, County Of Kent, US

Nicolas Kirchuk(Director, Chief Executive Officer, President)inRuben Javier Salanova(Director)

BoardConsuelo Valverde(Director)inPablo Fernandez(Director)Clarisa Diana Lifsic(Director, Treasurer)

Co-investorsOncology VenturesSV Latam CapitalZentynel Frontier InvestmentsAlpha Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.